Mesoblast (MESO) Non-Current Deferred Tax Liability (2015 - 2021)

Mesoblast's (MESO) quarterly Non-Current Deferred Tax Liability came in at $80.2 million in Q2 2021, up 10881.37% year-on-year from N/an in Q2 2020, and up 10881.37% quarter-over-quarter from $730000.0 in Q2 2020.

Mesoblast (MESO) Non-Current Deferred Tax Liability (2015 - 2021) Analysis & Trends

Mesoblast has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $80.2 million for Q2 2021.

  • Non-Current Deferred Tax Liability for Q2 2021 came in at $80.2 million, up 10881.37% year-over-year; the trailing twelve-month figure through Jun 2021 was $80.2 million (up 10881.37% YoY), and the FY2021 annual result was $80.2 million, up 10881.37% from the prior year.
  • Non-Current Deferred Tax Liability came in at $80.2 million for Q2 2021 at Mesoblast, up from $730000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $80.2 million in Q2 2021 to a low of $730000.0 in Q2 2020.
  • The 5-year median for Non-Current Deferred Tax Liability is $20.1 million (2018), against an average of $29.5 million.
  • Across the five-year window, Non-Current Deferred Tax Liability plunged 99.05% in 2020 and jumped 10881.37% in 2021, its largest moves.
  • Mesoblast's Non-Current Deferred Tax Liability stood at $23.9 million in 2017, then tumbled by 30.98% to $16.5 million in 2018, then plunged by 58.06% to $6.9 million in 2019, then slumped by 89.45% to $730000.0 in 2020, then surged by 10881.37% to $80.2 million in 2021.
  • The last three Non-Current Deferred Tax Liability figures came in at $80.2 million (Q2 2021), $730000.0 (Q2 2020), and $5.0 million (Q1 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mesoblast 21.68 Bn 21.55 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2021 80.16 Mn
Jun 30, 2021 80.16 Mn
Jun 30, 2020 730,000.00
Jun 30, 2020 730,000.00
Mar 31, 2020 4.97 Mn
Mar 31, 2020 4.97 Mn
Dec 31, 2019 6.92 Mn
Dec 31, 2019 6.92 Mn
Sep 30, 2019 9.20 Mn
Sep 30, 2019 9.20 Mn
Jun 30, 2019 76.55 Mn
Jun 30, 2019 76.55 Mn
Mar 31, 2019 14.30 Mn
Mar 31, 2019 14.30 Mn
Dec 31, 2018 16.50 Mn
Dec 31, 2018 16.50 Mn
Sep 30, 2018 19.37 Mn
Sep 30, 2018 19.37 Mn
Jun 30, 2018 20.08 Mn
Jun 30, 2018 20.08 Mn